1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Clinical Trials Imaging Market by Modality, End User, Product, and Region - Global Forecast to 2020

The global clinical trials imaging market is expected to USD 981.53 million by 2020 from USD 724.87 million in 2015, at a CAGR of 6.25% between 2015 and 2020. By product, the market includes services & software. The services product segment is further classified into operational imaging services, systems & technology, reader services & design consulting. Based on modality, the market is segmented into CT, MRI, ultrasound, PET, X-rays, ECHO ad other modalities. The CT segment will hold the largest share of the clinical trials imaging market in 2015.

The geographic segments included in this report are North America, Europe, Asia, and Rest of the World (RoW). North America is expected to account for the largest share in the global clinical trials imaging market in 2015. Asia is expected to register the fastest growth.

The growth of this market is mainly driven by growth in pharmaceutical & biotechnology industries, increase in R&D funding and increasing number of CROs. The high growth potential in emerging markets, provides new growth opportunities and development of innovative new imaging modalities, contrast agents, molecular probes & radiopharmaceuticals provides new growth trends to players in the clinical trials imaging market. Rising demand of multimodality imaging technology in clinical trials is the major trend of this market.

A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the global clinical trials imaging market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates. The report provides qualitative insights about growth rates, and market drivers for all subsegments. It maps market sizes and growth rates for each subsegment and identifies segments poised for rapid growth in each geographic segment. The report also includes company profiles of market leaders

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and to help them make important strategic growth decisions.

The report provides insights on the following:
- Product Development/Innovation: Product portfolios of the top players in the clinical trials imaging market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the insights on upcoming technologies market
- Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of the leading players in the clinical trials imaging market
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various clinical trials imaging across geographies
- Market Diversification: Exhaustive information about new products, recent developments, and investments in the clinical trials imaging market

Table Of Contents

Clinical Trials Imaging Market by Modality, End User, Product, and Region - Global Forecast to 2020
TABLE OF CONTENTS

1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 MARKET SCOPE 15
1.3.1 MARKETS COVERED 15
1.3.2 YEARS CONSIDERED IN THE REPORT 16
1.4 CURRENCY 17
1.5 LIMITATION 17
1.6 STAKEHOLDERS 17
2 RESEARCH METHODOLOGY 18
2.1 MARKET SIZE ESTIMATION 19
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 22
2.3 MARKET SHARE ESTIMATION 23
2.3.1 KEY DATA FROM SECONDARY SOURCES 23
2.3.2 KEY DATA FROM PRIMARY SOURCES 23
2.3.3 ASSUMPTIONS FOR THE STUDY 24
3 EXECUTIVE SUMMARY 25
4 PREMIUM INSIGHTS 30
4.1 GLOBAL CLINICAL TRIALS IMAGING MARKET OVERVIEW 30
4.2 LIFE CYCLE ANALYSIS, BY REGION (2015-2020) 32
5 MARKET OVERVIEW 33
5.1 INTRODUCTION 34
5.2 MARKET SEGMENTATION 34
5.2.1 BY PRODUCT 34
5.2.2 BY MODALITY 35
5.2.3 BY END USER 35
5.3 MARKET DYNAMICS 36
5.3.1 DRIVERS 37
5.3.1.1 Increase in RandD spending 37
5.3.1.2 Growth in the pharmaceutical and biotechnology industries 38
5.3.1.3 Increasing number of CROs 38
5.3.2 RESTRAINTS 39
5.3.2.1 High implementation cost of imaging systems 39

5.3.3 OPPORTUNITIES 40
5.3.3.1 Emerging economies 40
5.3.3.2 Development of innovative imaging modalities, contrast agents, molecular probes, and radiopharmaceuticals 41
5.3.4 CHALLENGES 41
5.3.4.1 High cost of clinical trials 41
5.3.4.2 High cost of PET 41
5.3.5 TRENDS 42
5.3.5.1 Rising demand for multimodality imaging technology in clinical trials 42
6 CLINICAL TRIALS IMAGING MARKET, BY PRODUCT 43
6.1 INTRODUCTION 44
6.2 SERVICES 46
6.2.1 OPERATIONAL IMAGING 48
6.2.2 READ ANALYSIS 50
6.2.3 SYSTEM AND TECHNICAL SUPPORT 52
6.2.4 TRIAL DESIGN CONSULTING 53
6.3 SOFTWARE 55
7 CLINICAL TRIALS IMAGING MARKET, BY MODALITY 57
7.1 INTRODUCTION 58
7.2 COMPUTED TOMOGRAPHY 60
7.3 MAGNETIC RESONANCE IMAGING 62
7.4 ULTRASOUND 64
7.5 POSITRON EMISSION TOMOGRAPHY 66
7.6 X-RAY 68
7.7 ECHOCARDIOGRAPHY 69
7.8 OTHER MODALITIES 71
8 CLINICAL TRIALS IMAGING MARKET, BY END USER 73
8.1 INTRODUCTION 74
8.2 PHARMACEUTICAL COMPANIES 76
8.3 BIOTECHNOLOGY COMPANIES 78
8.4 MEDICAL DEVICE MANUFACTURERS 80
8.5 CONTRACT RESEARCH ORGANIZATIONS 82
8.6 ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES 84
8.7 OTHER END USERS 86

9 GEOGRAPHIC ANALYSIS 88
9.1 INTRODUCTION 89
9.2 NORTH AMERICA 91
9.3 EUROPE 98
9.4 ASIA 103
9.5 REST OF THE WORLD (ROW) 109
10 COMPETITIVE LANDSCAPE 114
10.1 INTRODUCTION 114
10.2 STRATEGIC OVERVIEW 114
10.3 LEADING PLAYERS IN THE CLINICAL TRIALS IMAGING MARKET 115
10.4 COMPETITIVE SITUATION AND TRENDS 116
10.4.1 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS 117
10.4.2 ACQUISITIONS 118
10.4.3 NEW PRODUCT AND SERVICE LAUNCHES and PRODUCT UPGRADES 119
10.4.4 EXPANSIONS 120
10.4.5 OTHER DEVELOPMENTS 121
11 COMPANY PROFILES 122
(Overview, Financials, Products and Services, Strategy, and Developments)*
11.1 INTRODUCTION 122
11.2 BIOCLINICA, INC. 123
11.3 PAREXEL INTERNATIONAL CORPORATION 125
11.4 ICON PUBLIC LIMITED COMPANY 128
11.5 BIOMEDICAL SYSTEMS CORPORATION 131
11.6 VIRTUALSCOPICS, INC. 133
11.7 CARDIOVASCULAR IMAGING TECHNOLOGIES, LLC 135
11.8 INTRINSIC IMAGING LLC 136
11.9 IXICO PLC 137
11.10 RADIANT SAGE LLC 139
11.11 WORLDCARE CLINICAL, LLC 140
*Details on Financials, Product and Services, Strategy, and Developments might not be captured in case of unlisted companies.
12 APPENDIX 141
12.1 INSIGHTS OF INDUSTRY EXPERTS 141
12.2 DISCUSSION GUIDE 142
12.3 OTHER DEVELOPMENTS 144
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 146
12.5 AVAILABLE CUSTOMIZATIONS 147
12.6 RELATED REPORTS 148


LIST OF TABLES

TABLE 1 CLINICAL TRIALS IMAGING MARKET SUMMARY 25
TABLE 2 INCREASE IN RandD SPENDING IS PROPELLING THE GROWTH OF THE CLINICAL TRIALS IMAGING MARKET 39
TABLE 3 HIGH IMPLEMENTATION COST OF IMAGING SYSTEMS TO RESTRAIN MARKET GROWTH 39
TABLE 4 EMERGING ECONOMIES OFFER SIGNIFICANT GROWTH OPPORTUNITIES 41
TABLE 5 HIGH COST OF CLINICAL TRIALS POSE A CHALLENGE FOR THE CLINICAL TRIALS IMAGING MARKET 42
TABLE 6 RISING DEMAND FOR MULTIMODALITY IMAGING TECHNOLOGY IN CLINICAL TRIALS IS A MAJOR TREND OBSERVED IN THIS MARKET 42
TABLE 7 CLINICAL TRIALS IMAGING MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 45
TABLE 8 CLINICAL TRIALS IMAGING SERVICES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 46
TABLE 9 CLINICAL TRIALS IMAGING SERVICES MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 47
TABLE 10 NORTH AMERICA: CLINICAL TRIALS IMAGING SERVICES MARKET SIZE,
BY COUNTRY, 2013-2020 (USD MILLION) 48
TABLE 11 CLINICAL TRIALS IMAGING MARKET SIZE FOR OPERATIONAL IMAGING,
BY REGION, 2013-2020 (USD MILLION) 49
TABLE 12 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR OPERATIONAL IMAGING, BY COUNTRY, 2013-2020 (USD MILLION) 49
TABLE 13 CLINICAL TRIALS IMAGING MARKET SIZE FOR READ ANALYSIS, BY REGION,
2013-2020 (USD MILLION) 51
TABLE 14 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR READ ANALYSIS, BY COUNTRY, 2013-2020 (USD MILLION) 51
TABLE 15 CLINICAL TRIALS IMAGING MARKET SIZE FOR SYSTEM AND TECHNICAL SUPPORT, BY REGION, 2013-2020 (USD MILLION) 52
TABLE 16 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR SYSTEM AND TECHNICAL SUPPORT, BY COUNTRY, 2013-2020 (USD MILLION) 53
TABLE 17 CLINICAL TRIALS IMAGING MARKET SIZE FOR TRIAL DESIGN CONSULTING,
BY REGION, 2013-2020 (USD MILLION) 54
TABLE 18 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR TRIAL DESIGN CONSULTING, BY COUNTRY, 2013-2020 (USD MILLION) 54
TABLE 19 CLINICAL TRIALS IMAGING SOFTWARE MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 55
TABLE 20 NORTH AMERICA: CLINICAL TRIALS IMAGING SOFTWARE MARKET SIZE,
BY COUNTRY, 2013-2020 (USD MILLION) 56
TABLE 21 CLINICAL TRIALS IMAGING MARKET SIZE, BY MODALITY,
2013-2020 (USD MILLION) 59
TABLE 22 CLINICAL TRIALS IMAGING MARKET SIZE FOR CT, BY REGION,
2013-2020 (USD MILLION) 61
TABLE 23 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR CT,
BY COUNTRY, 2013-2020 (USD MILLION) 61
TABLE 24 CLINICAL TRIALS IMAGING MARKET SIZE FOR MRI, BY REGION,
2013-2020 (USD MILLION) 63
TABLE 25 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR MRI,
BY COUNTRY, 2013-2020 (USD MILLION) 63
TABLE 26 CLINICAL TRIALS IMAGING MARKET SIZE FOR ULTRASOUND, BY REGION,
2013-2020 (USD MILLION) 65
TABLE 27 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR ULTRASOUND,
BY COUNTRY, 2013-2020 (USD MILLION) 65
TABLE 28 CLINICAL TRIALS IMAGING MARKET SIZE FOR PET, BY REGION,
2013-2020 (USD MILLION) 67
TABLE 29 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR PET,
BY COUNTRY, 2013-2020 (USD MILLION) 67
TABLE 30 CLINICAL TRIALS IMAGING MARKET SIZE FOR X-RAY, BY REGION,
2013-2020 (USD MILLION) 68
TABLE 31 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR X-RAY,
BY COUNTRY, 2013-2020 (USD MILLION) 69
TABLE 32 CLINICAL TRIALS IMAGING MARKET SIZE FOR ECHOCARDIOGRAPHY,
BY REGION, 2013-2020 (USD MILLION) 70
TABLE 33 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR ECHOCARDIOGRAPHY, BY COUNTRY, 2013-2020 (USD MILLION) 70
TABLE 34 CLINICAL TRIALS IMAGING MARKET SIZE FOR OTHER MODALITIES,
BY REGION, 2013-2020 (USD MILLION) 71
TABLE 35 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR OTHER MODALITIES, BY COUNTRY, 2013-2020 (USD MILLION) 72
TABLE 36 CLINICAL TRIALS IMAGING MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 75
TABLE 37 CLINICAL TRIALS IMAGING MARKET SIZE FOR PHARMACEUTICAL COMPANIES,
BY REGION, 2013-2020 (USD MILLION) 77
TABLE 38 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2013-2020 (USD MILLION) 78
TABLE 39 CLINICAL TRIALS IMAGING MARKET SIZE FOR BIOTECHNOLOGY COMPANIES,
BY REGION, 2013-2020 (USD MILLION) 79
TABLE 40 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2013-2020 (USD MILLION) 80
TABLE 41 CLINICAL TRIALS IMAGING MARKET SIZE FOR MEDICAL DEVICE MANUFACTURERS, BY REGION, 2013-2020 (USD MILLION) 81
TABLE 42 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR MEDICAL DEVICE MANUFACTURERS, BY COUNTRY, 2013-2020 (USD MILLION) 82
TABLE 43 CLINICAL TRIALS IMAGING MARKET SIZE FOR CROS, BY REGION,
2013-2020 (USD MILLION) 83
TABLE 44 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR CROS,
BY COUNTRY, 2013-2020 (USD MILLION) 84
TABLE 45 CLINICAL TRIALS IMAGING MARKET SIZE FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2013-2020 (USD MILLION) 85
TABLE 46 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2013-2020 (USD MILLION) 86
TABLE 47 CLINICAL TRIALS IMAGING MARKET SIZE FOR OTHER END USERS, BY REGION, 2013-2020 (USD MILLION) 87
TABLE 48 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2013-2020 (USD MILLION) 87
TABLE 49 CLINICAL TRIALS IMAGING MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 89
TABLE 50 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 93
TABLE 51 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 94
TABLE 52 NORTH AMERICA: CLINICAL TRIALS IMAGING SERVICES MARKET SIZE,
BY TYPE, 2013-2020 (USD MILLION) 95
TABLE 53 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE, BY MODALITY,
2013-2020 (USD MILLION) 96
TABLE 54 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 97
TABLE 55 EUROPE: CLINICAL TRIALS IMAGING MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 99
TABLE 56 EUROPE: CLINICAL TRIALS IMAGING SERVICES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 100
TABLE 57 EUROPE: CLINICAL TRIALS IMAGING MARKET SIZE, BY MODALITY,
2013-2020 (USD MILLION) 101
TABLE 58 EUROPE: CLINICAL TRIALS IMAGING MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 102
TABLE 59 ASIA: CLINICAL TRIALS IMAGING MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 105
TABLE 60 ASIA: CLINICAL TRIALS IMAGING SERVICES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 106
TABLE 61 ASIA: CLINICAL TRIALS IMAGING MARKET SIZE, BY MODALITY,
2013-2020 (USD MILLION) 107
TABLE 62 ASIA: CLINICAL TRIALS IMAGING MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 108
TABLE 63 ROW: CLINICAL TRIALS IMAGING MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 110
TABLE 64 ROW: CLINICAL TRIALS IMAGING SERVICES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 111
TABLE 65 ROW: CLINICAL TRIALS IMAGING MARKET SIZE, BY MODALITY,
2013-2020 (USD MILLION) 112
TABLE 66 ROW: CLINICAL TRIALS IMAGING MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 113
TABLE 67 RANK OF COMPANIES IN THE GLOBAL CLINICAL TRIALS IMAGING MARKET, 2015 115
TABLE 68 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS WAS THE KEY STRATEGY ADOPTED BY PLAYERS BETWEEN JANUARY 2013 AND AUGUST 2015 116
TABLE 69 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2013-2015 117
TABLE 70 ACQUISITIONS, 2013-2015 118
TABLE 71 NEW PRODUCT AND SERVICE LAUNCHES and PRODUCT UPGRADES, 2013-2015 119
TABLE 72 EXPANSIONS, 2013-2015 120
TABLE 73 OTHER DEVELOPMENTS, 2013-2015 121
TABLE 74 MARKET DEVELOPMENTS BETWEEN JANUARY 2013 AND AUGUST 2015 122


LIST OF FIGURES

FIGURE 1 CLINICAL TRIALS IMAGING MARKET 16
FIGURE 2 RESEARCH DESIGN 18
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 20
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 20
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 21
FIGURE 6 DATA TRIANGULATION METHODOLOGY 22
FIGURE 7 CLINICAL TRIALS IMAGING MARKET SIZE, BY PRODUCT,
2015 VS. 2020 (USD MILLION) 26
FIGURE 8 CLINICAL TRIALS IMAGING MARKET SIZE, BY MODALITY,
2015 VS. 2020 (USD MILLION) 26
FIGURE 9 CLINICAL TRIALS IMAGING MARKET SIZE, BY END USER,
2015 VS. 2020 (USD MILLION) 27
FIGURE 10 CLINICAL TRIALS IMAGING MARKET: GEOGRAPHIC SNAPSHOT (2015) 28
FIGURE 11 CLINICAL TRIALS IMAGING MARKET SIZE, BY REGION,
2015 VS. 2020 (USD MILLION) 28
FIGURE 12 EMERGING ECONOMIES OFFER SIGNIFICANT GROWTH OPPORTUNITIES FOR MARKET GROWTH 30
FIGURE 13 SERVICES SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2015 31
FIGURE 14 ASIA TO WITNESS HIGHEST GROWTH RATE IN THE FORECAST PERIOD 31
FIGURE 15 NORTH AMERICA MARKET SEGMENT HEADED TOWARD MATURITY 32
FIGURE 16 CLINICAL TRIALS IMAGING MARKET: BY PRODUCT 34
FIGURE 17 CLINICAL TRIALS IMAGING MARKET: BY MODALITY 35
FIGURE 18 CLINICAL TRIALS IMAGING MARKET: BY END USER 35
FIGURE 19 INCREASE IN RandD SPENDING WILL DRIVE THE CLINICAL TRIALS IMAGING MARKET 36
FIGURE 20 INCREASING RandD FUNDING BOOSTING GROWTH IN THE CLINICAL TRIALS IMAGING MARKET 37
FIGURE 21 NUMBER OF BIOTECHNOLOGY PATENTS, BY COUNTRY, 2012 40
FIGURE 22 CLINICAL TRIALS IMAGING MARKET SEGMENTATION, BY PRODUCT 44
FIGURE 23 CLINICAL TRIALS IMAGING SERVICES TO FORM THE LARGEST SEGMENT IN 2015 45
FIGURE 24 OPERATIONAL IMAGING TO FORM THE LARGEST AND FASTEST-GROWING SEGMENT IN THE FORECAST PERIOD 46
FIGURE 25 NORTH AMERICA TO BE THE LARGEST SEGMENT OF THE CLINICAL TRIALS IMAGING SERVICES MARKET IN 2015 47
FIGURE 26 ASIA TO BE THE FASTEST-GROWING SEGMENT OF THE OPERATIONAL IMAGING MARKET IN THE FORECAST PERIOD 48
FIGURE 27 NORTH AMERICA TO FORM THE LARGEST SEGMENT OF THE READ ANALYSIS MARKET IN 2015 50
FIGURE 28 ASIA TO FORM THE FASTEST-GROWING SEGMENT OF THE SYSTEM AND TECHNICAL SUPPORT MARKET IN THE FORECAST PERIOD 52
FIGURE 29 NORTH AMERICA TO COMMAND LARGEST SHARE OF THE TRIAL DESIGN CONSULTING MARKET IN THE FORECAST PERIOD 53
FIGURE 30 ASIA TO BE THE FASTEST-GROWING SEGMENT OF THE CLINICAL TRIALS IMAGING SOFTWARE MARKET IN THE FORECAST PERIOD 55
FIGURE 31 CLINICAL TRIALS IMAGING MARKET SEGMENTATION, BY MODALITY 58
FIGURE 32 CT SEGMENT TO COMMAND THE LARGEST SHARE OF THE CLINICAL TRIALS IMAGING MARKET IN 2015 58
FIGURE 33 NORTH AMERICA EXPECTED TO DOMINATE THE CLINICAL TRIALS IMAGING MARKET FOR CT IN 2015 60
FIGURE 34 ASIA TO WITNESS HIGHEST GROWTH IN THE CLINICAL TRIALS IMAGING MARKET FOR MRI IN THE FORECAST PERIOD 62
FIGURE 35 NORTH AMERICA EXPECTED TO FORM THE LARGEST REGIONAL SEGMENT FOR ULTRASOUND IN 2015 64
FIGURE 36 ASIA EXPECTED TO BE THE FASTEST-GROWING REGIONAL SEGMENT FOR PET MARKET BETWEEN 2015 AND 2020 66
FIGURE 37 X-RAY MARKET IN ASIA TO WITNESS HIGHEST GROWTH IN THE FORECAST PERIOD 68
FIGURE 38 ECHOCARDIOGRAPHY MARKET IN ASIA TO WITNESS HIGHEST GROWTH IN THE FORECAST PERIOD 69
FIGURE 39 NORTH AMERICA DOMINATES THE MARKET FOR OTHER MODALITIES IN 2015 71
FIGURE 40 CLINICAL TRIALS IMAGING MARKET, BY END USER 74
FIGURE 41 CLINICAL TRIALS IMAGING MARKET SIZE, BY END USER, 2015 (USD MILLION) 74
FIGURE 42 NUMBER OF BIOTECHNOLOGY AND PHARMACEUTICAL PATENTS GRANTED IN 2012, BY REGION 76
FIGURE 43 PHARMACEUTICAL COMPANIES SEGMENT TO WITNESS HIGHEST GROWTH IN ASIA IN 2015 77
FIGURE 44 NORTH AMERICA TO BE THE LARGEST SEGMENT OF THE BIOTECHNOLOGY COMPANIES SEGMENT IN 2020 79
FIGURE 45 NORTH AMERICA TO DOMINATE THE CLINICAL TRIALS IMAGING MARKET FOR MEDICAL DEVICE MANUFACTURERS IN 2020 81
FIGURE 46 NORTH AMERICA EXPECTED TO DOMINATE THE CLINICAL TRIALS IMAGING MARKET FOR CROS IN 2020 83
FIGURE 47 PUBLIC-SECTOR RESEARCH FUNDING IS DRIVING THE GROWTH OF THE ACADEMIC and GOVERNMENT RESEARCH INSTITUTES END-USER SEGMENT 84
FIGURE 48 NORTH AMERICA DOMINATES THE MARKET FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES IN 2015 85
FIGURE 49 ASIA TO WITNESS THE HIGHEST GROWTH IN THE CLINICAL TRIALS IMAGING MARKET FOR OTHER END USERS IN THE FORECAST PERIOD 86
FIGURE 50 CLINICAL TRIALS IMAGING MARKET, BY REGION (MARKET SIZE AND GROWTH RATE), 2015-2020 89
FIGURE 51 CLINICAL TRIALS IMAGING MARKET IN ASIA EXPECTED TO GROW AT THE HIGHEST RATE FROM 2015 TO 2020 90
FIGURE 52 NORTH AMERICA: MARKET SNAPSHOT 92
FIGURE 53 U.S. FORMS THE FASTEST-GROWING MARKET IN NORTH AMERICA IN 2015 93
FIGURE 54 SERVICES ARE ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN NORTH AMERICA (2015) 94
FIGURE 55 OPERATIONAL IMAGING LARGEST SERVICES SEGMENT IN NORTH AMERICA (2015) 95
FIGURE 56 CT EXPECTED TO FORM FOR THE LARGEST MODALITY SEGMENT IN NORTH AMERICA IN 2015 96
FIGURE 57 PHARMACEUTICAL COMPANIES TO FORM THE LARGEST END-USER SEGMENT IN NORTH AMERICA IN 2015 97
FIGURE 58 SERVICES TO FORM THE LARGEST PRODUCT SEGMENT IN EUROPE 2015 99
FIGURE 59 OPERATIONAL IMAGING ACCOUNTED FOR THE LARGEST SHARE IN THE EUROPEAN CLINICAL TRIALS IMAGING MARKET IN 2015 100
FIGURE 60 CT SEGMENT TO COMMAND THE LARGEST SHARE OF THE EUROPEAN CLINICAL TRIALS IMAGING MARKET IN 2015 101
FIGURE 61 PHARMACEUTICAL COMPANIES TO FORM THE LARGEST END-USER SEGMENT IN EUROPE IN 2015 102
FIGURE 62 ASIA: MARKET SNAPSHOT 104
FIGURE 63 SERVICES TO FORM THE LARGEST PRODUCT SEGMENT IN ASIA (2015) 105
FIGURE 64 OPERATIONAL IMAGING TO FORM THE LARGEST SERVICES SEGMENT IN ASIA
IN 2015 106
FIGURE 65 CT SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE CLINICAL TRIALS IMAGING MARKET IN ASIA 107
FIGURE 66 PHARMACEUTICAL COMPANIES TO FORM THE LARGEST END-USER SEGMENT IN ASIA IN 2015 108
FIGURE 67 SERVICES TO FORM THE LARGEST PRODUCT SEGMENT IN THE ROW IN 2015 110
FIGURE 68 OPERATIONAL IMAGING TO COMMAND THE LARGEST SHARE IN THE ROW CLINICAL TRIALS IMAGING MARKET (2015) 111
FIGURE 69 CT TO FORM THE LARGEST MODALITY SEGMENT IN ROW IN 2015 112
FIGURE 70 PHARMACEUTICAL COMPANIES TO FORM THE LARGEST END-USER SEGMENT IN ROW IN 2015 113
FIGURE 71 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS IS THE KEY GROWTH STRATEGY ADOPTED BY PLAYERS IN THE CLINICAL TRIALS IMAGING MARKET, 2013-2015 114
FIGURE 72 COMPANY SNAPSHOT: PAREXEL INTERNATIONAL CORPORATION 125
FIGURE 73 COMPANY SNAPSHOT: ICON PUBLIC LIMITED COMPANY 128
FIGURE 74 COMPANY SNAPSHOT: VIRTUALSCOPICS, INC. 133
FIGURE 75 COMPANY SNAPSHOT: IXICO PLC 137

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.